The Effects of Cognitive-motor Dual-task Intervention on Fall Prevention Among Older Adults (NCT07025278) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Effects of Cognitive-motor Dual-task Intervention on Fall Prevention Among Older Adults
125 participantsStarted 2027-03-31
Plain-language summary
1. Develop an evidence-based dual-task intervention programme incorporating gamification for fall risk reduction in older adults.
2. Examine the effects of the gamified dual-task intervention on fall risk in older adults.
3. Elucidate the underlying mechanisms of the optimal gamified dual-task intervention programme in reducing falls in older adults.
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age ≥ 65 years old;
. Able to walk independently for at least 10 meters without obvious pain or difficulty;
. Free from lower limb and foot deformities, wounds, ulcers, or other diseases, and capable of wearing flexible devices;
. Scored as low or moderate fall risk on the Morse Fall Risk Assessment Scale;
. Scored \> 40 points on the Berg Balance Scale and \< 20 seconds on the Time Up and Go Test (TUG);
. Scored ≥ 21 points on the Mini-Mental State Examination (MMSE);
. With an educational level of primary school or above, able to correctly understand instructions and make corresponding responses;
. Without diseases that severely affect cognitive and motor functions, including cardiovascular diseases (such as uncontrolled hypertension, heart failure, etc.), neurological diseases (such as Parkinson's disease, stroke, epilepsy, etc.), musculoskeletal diseases (such as severe arthritis, recent fractures, etc.), etc.;
Exclusion criteria
. Must rely on assistive walking devices or others to walk;
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The changes of Time up and go test from baseline to the end of the intervention
Timeframe: From enrollment to the end of the intervention at 3 weeks